Scleroderma
We correct the immune response to stop excessive collagen production and protect internal organs.
About the disease
Scleroderma is characterized by excessive formation of connective tissue and damage to the skin and internal organs.
Immunotherapy aims to correct the pathological immune response underlying the disease.
Organ protection
Reducing the risk of internal organ damage.
Fibrosis control
Inhibition of excessive collagen production.
Systemic correction
Impact on the disease mechanism.
T-cell vaccination
The method aims to stimulate immune reactions selectively directed at inactivating pathogenic autoimmune T-lymphocytes.
Collection and isolation
Autoaggressive T-lymphocytes — cells attacking the body's own tissues — are isolated from your blood.
Vaccine preparation
The isolated cells are processed and used to create a personalized T-cell vaccine.
Vaccination
Administering the vaccine triggers a regulatory immune response that selectively suppresses only the pathogenic cell clones.
Monitoring and support
Inflammatory activity decreases without suppressing general immunity; the course is adjusted based on dynamics.
Other directions
Multiple sclerosis
Selective inactivation of aggressive lymphocytes to protect the myelin sheath of nerve fibers.
Ankylosing spondylitis
Targeted reduction of inflammatory activity in the spine, preventing joint fusion.
Autoimmune vasculitis
Relieving inflammation of the vascular wall to restore normal blood circulation.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.